A 55-year-old with T2D and obesity (BMI 35) without ASCVD has A1c 8.3% on metformin. eGFR 65. Which glucose-lowering agent has proven cardiorenal bene...

Question

A 55-year-old with T2D and obesity (BMI 35) without ASCVD has A1c 8.3% on metformin. eGFR 65. Which glucose-lowering agent has proven cardiorenal benefit and weight loss?

Accepted Answer

SGLT2 inhibitor or GLP-1 RA with CV benefit

Answer

Sulfonylurea

Answer

Basal insulin

Answer

DPP-4 inhibitor

Answer

Thiazolidinedione

us-usmle-step-2 MCQ (SBA): Type 2 Diabetes Mellitus

A 55-year-old with T2D and obesity (BMI 35) without ASCVD has A1c 8.3% on metformin. eGFR 65. Which glucose-lowering agent has proven cardiorenal benefit and weight loss?